Search Results - "Gonzalez, M.A. Sala"

236P Predicting Oncotype DX recurrence scores using clinicopathologic features: Tennessee University Nomogram: An external validation by Pikabea Díaz, F., Galve Calvo, E., Zumarraga, A., Figaredo Bejarano, C., Sala Gonzalez, M.A., Lopez Santillan, M., Lopez De San Vicente, B., Casado, P., Martinez del Prado, M.P.

Get full text

1630P Effectivity and safety of anti-SARS-CoV2 vaccination in patients with lung cancer: The VAC-CaP observational study (GECP 21/01) by Nadal, E., Moran Bueno, M.T., Rodriguez Abreu, D., Vidales Sepulveda, Z., Sala Gonzalez, M.A., Antonanzas Basa, M., Garcia Gonzalez, J.J., Diz Tain, P., Martinez Kareaga, M., Lopez Vivanco, G., Baena Espinar, J., Campos Balea, B., Cumplido Buron, D., Cerezo Gonzalez, S., Diaz, A., Guirado, M., Mielgo Rubio, X., Juan Vidal, O.J., Saigi Morgui, M., Provencio Pulla, M.

Get full text

1362MO Pembrolizumab + olaparib vs abiraterone (abi) or enzalutamide (enza) for patients (pts) with previously treated metastatic castration-resistant prostate cancer (mCRPC): Randomized open-label phase III KEYLYNK-010 study by Yu, E.Y., Park, S.H., Goh, J.C.H., Shin, S.J., Mehra, N., McDermott, R., Sala Gonzalez, M.A., Fong, P.C., Greil, R., Retz, M., Sade, J.P., Huang, Y-H., Begbie, S., Rey, F., Kramer, G., Suzuki, H., Zhang, J., Kim, J., Poehlein, C.H., Antonarakis, E.S.

Get full text

39P Determination of essential biomarkers in lung cancer: A real-world data study in Spain by Calvo de Juan, V., Cobo Dols, M., Rodriguez-Abreu, D., Carcereny, E., Cantero, A., Bernabé Caro, R., Benitez Lopez, G., Lopez Castro, R., Massuti Sureda, B., del Barco, E., Garcia Campelo, M.R., Guirado, M., Camps Herrero, C.J.C., Ortega Granados, A.L.O., Gonzalez-Larriba, J.L., Sanchez Hernandez, A., Gonzalez Ojea, C., Sala Gonzalez, M.A., Juan Vidal, O.J., Provencio Pulla, M.

Get full text

160P Pembrolizumab re-challenge in patients with relapsed non-small cell lung cancer (NSCLC): A preliminary report of the REPLAY phase II trial - cohort I by Ponce Aix, S., Carcereny Costa, E., Bosch-Barrera, J., Felip Font, E., Guirado, M., Coves Sarto, J., Majem Tarruella, M., Juan Vidal, O.J., Dalmau Portulas, E., Diz, P., Ortega Granados, A.L.O., Domine Gomez, M., Blasco Cordellat, A., Mosquera Martinez, J., Sala Gonzalez, M.A., Dorta, M., Calvo de Juan, V., Zugazagoitia, J., Enguita, A.B., Paz-Ares, L.

Get full text

1168P Clinical characteristics and survival in stage I-IIIA lung cancer resected patients in Spain, analyzed in the Thoracic Tumors Registry (TTR) by Franco, F.F., Carcereny, E., Castro, R. Lopez, Rodriguez, D., Dols, M.A. Cobo, Caro, R. Bernabe, Cordellat, A. Blasco, Sureda, B. Massuti, Granados, A.L. Ortega, Barco, E. del, Bosch-Barrera, J., Guirado, M., Gonzalez-Larriba, J.L., Vidal, O. Juan, Martinez, J. Mosquera, Rodriguez, J.M. Oramas, Gonzalez, M.A. Sala, Calvo, V., Gonzalez, A. Estival, Provencio, M.

Get full text

PO-14: Real-world data: incidence of venous thromboembolism recurrence and bleeding among cancer patients by Silva-Cardenas, D.C., Pikabea-Diaz, F., Zumarraga-Cuesta, A., Lopez-Santillan, M., Figaredo-Berjano, C., Loaiza-Jaramillo, P.L., Casado-Cuesta, P., Temiño-Frances, M., Lopez-de-San-Vicente-Hernandez, B., Novo-Sukia, E., Legaspi-Folgueira, J., Barcelo-Galindez, J.R., Sande-Sardina, L., Nuno-Escolastico, M., Abad-Villar, M.T., Sala-Gonzalez, M.A., Galve-Calvo, E., Martinez-del-Prado, M.P.

Get full text

1786P Small cell lung cancer (SCLC) extensive stage (ES) in Spain: Efficacy of treatments, data from the thoracic tumours registry (TTR study) by Carcereny Costa, E., Calvo, V., Guirado, M., Ortega Granados, A.L., Lopez Castro, R., Rodriguez-Abreu, D., Mosquera Martinez, J., del Barco Morillo, E., Juan-Vidal, O., Sanchez Hernandez, A., Sala Gonzalez, M.A., Blanco Guerrero, R., Bernabe Caro, R., Alonso, R., Garcia Benito, C., Oramas Rodriguez, J.M., Diz Tain, P., Nogueron Martinez, E., Guirao Rubio, C.M., Provencio Pulla, M.

Get full text

1784P Activity of lurbinectedin in second-line SCLC patients candidates for platinum re-challenge by Subbiah, V., Paz-Ares, L., Besse, B., Moreno, V., Zaman, K., Sala Gonzalez, M.A., Lopez-Vilarino, J.A., Fernandez, C.M., Kahatt, C., Siguero, M., Zeaiter, A., Lopez Lopez, R., Ponce Aix, S., Boni, V., Arrondeau, J., Delord, J-P., Martínez-Aguillo, M., Wannesson De Nicola, L., Anton Torres, A., Trigo Perez, J.M.

Get full text

1380P Description of the clinical characteristics and survival in patients with metastatic NSCLC in the Spanish population: An analysis of the thoracic tumours registry (RTT study) by Franco, F., Costa, E. Carcereny, Rodriguez-Abreu, D., Castro, R. Lopez, Dols, M. Cobo, Guirado, M., Sureda, B. Massuti, Granados, A.L. Ortega, Campelo, R. Garcia, Juan-Vidal, O., Cordellat, A. Blasco, Morillo, E. del Barco, Caro, R. Bernabe, Bosch-Barrera, J., Gonzalez-Larriba, J.L., Gonzalez, M.A. Sala, Perez, J.M. Trigo, Rodriguez, J.M. Oramas, Estival, A., Pulla, M. Provencio

Get full text

Surgery of the primary tumor for de novo metastatic breast cancer: The controversy continues by López de San Vicente, B., Galve Calvo, E., Zumarraga, A., Pikab ea, F., Arango Arteaga, J.F., López Santillan, M., Figaredo, C., Sala Gonzalez, M.A., Nuño Escolastico, M., Novas Vidal, P., Legaspi, J., Martinez del Prado, P.

Get full text

Preliminar analysis of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC): NORA trial (GECP 15/02) by Majem Tarruella, M., Isla Casado, L., Guirado, M., Massuti Sureda, B., Ortega Granados, A.L., Marse Fabregat, R., Domine Gomez, M., de las Peñas, R., Moran Bueno, M.T., Vazquez Estevez, S., Sala Gonzalez, M.A., Coves Sarto, J., Sánchez-Torres, J.M., Vicente Baz, D., Gonzalez-Larriba, J., Paredes, A., Farré, N., Fernández Fornos, L., Mena, A., Provencio Pulla, M.

Get full text

A randomized double-blind phase II trial evaluating maintenance PARP inhibitor Olaparib versus placebo in patients with platinum-sensitive advanced non-small cell lung cancer: PIPSeN trial by Postel-Vinay, S., Planchard, D., Ortega Granados, A.L., Gazzah, A., Sala Gonzalez, M.A., Majem, M., Camps, C.J., Abou-Lauvergne, A., Pignon, J.-P., Cadranel, J., Bennouna, J., Barlesi, F., Garcia Campelo, M.R., Viteri, S., Besse, B., Coves Sarto, J., Massuti Sureda, B., Soria, J.-C., Rosell, R.

Get full text

275P Serological response to COVID-19 vaccine in patients with advanced breast cancer by Cuesta, P. Casado, Díaz, F. Pikabea, Galve-Calvo, E., Zumarraga, A., Penas, A. Bilbao, De San Vicente, B. López, Bejarano, C. Figaredo, Pina, I. Bernat, Legaspi, J., Galíndez, J.R. Barceló, Sardina, L. Sande, NuÑo Escolastico, M., Abad Villar, M.T., Lopez, M., Pérez Hoyos, M.T., Sala Gonzalez, M.A., Francés, M. Temiño, Jaramillo, P.L. Loaiza, Díaz de Tuesta del Arco, J.L., Martinez del Prado, P.

Get full text

Final results of RENO study: Randomized phase II of oral vinorelbine or etoposide with cisplatin & chemo-radiation in stage III NSCLC - SLCG 10/02 by Provencio Pulla, M., de las Peñas, R., Martinez Banaclocha, N., MarsÉ Fabregat, R., Insa Molla, A., Moran, T., Sala Gonzalez, M.A., Massuti Sureda, B., Mut Sanchis, P., Ortega Granados, A.L., Jurado, J.M., Gomez Codina, J., Artal-Cortes, A., Vazquez, F., Gutierrez Calderon, V., Diz Tain, P., Vinolas Segarra, N., Maestu Maiques, I., Camps, C., Isla Casado, M.D.

Get full text

First analysis of patients (p) with stage IV non-small cell lung cancer (NSCLC) of the thoracic tumor registry (RTT) of the Spanish Lung Cancer Group (SLCG) by Carcereny Costa, E., Rodriguez-Abreu, D., Guirado, M., López-Castro, R., Massutí, B., Bosch Barrera, J., Nogueron Martnez, E., Sala Gonzalez, M.A., Domine Gomez, M., Del Barco Morillo, E., Cerezo Gonzalez, S., Dorta Suarez, M., Casal Rubio, J., Camps, C., Muñoz, M.A., de las Peñas, R., Ortega dominguez, J.A., Gonzalez-Larriba, J.L., Bernabe Caro, R., Provencio Pulla, M.

Get full text

1452PMULTIDISCIPLINARY TREATMENT OUTCOME OF DESMOID-TYPE FIBROMATOSIS (DTF). A REGISTRY-BASED STUDY FROM SPANISH GROUP FOR RESEARCH ON SARCOMA (GEIS) by Martinez-Trufero, J., Alvarez Alvarez, R., Lopez Pousa, A., Sevilla, I., Sancho Marquez, P., Orbegoso, C., Cruz Jurado, J., Sala Gonzalez, M.A., Valverde Morales, C., Blanco Sanchez, M.J., Pérez-Fidalgo, J.A., Berros, J.P., Martinez García, J., Arranz, J.L., Meana, A., López-Martín, J.A., Rubió, J., Cano, J.M., Juez-Martel, I., Martin Broto, J.

“…Abstract Aim: We analyzed retrospectively data about treatment outcome with existing treatments in DTF. Methods: Descriptive analysis of data related to…”
Get full text

Solitary Fibrous Tumor (Sft): a Registry Program to Assess Frequency and Managemente in Our Country. a Spanish Group for Research on Sarcoma (Geis) Study by Cruz Jurado, J., Valverde Morales, C., Vaz, M.A., Alvarez Alvarez, R., Lopez-Pousa, A., Sancho Marquez, P., Carrasco, J.A., Martinez-Trufero, J., Sala Gonzalez, M.A., Arranz, J.L., De Sande González, L.M., Blanco Sanchez, M.J., Orbegoso, C., Pérez-Fidalgo, J.A., Martinez García, J., Lavernia, J., Sevilla, I., Cano, J.M., Meana, A., Martin Broto, J.

Get full text

Multidisciplinary Treatment Outcome of Desmoid-Type Fibromatosis (Dtf). a Registry-Based Study from Spanish Group for Research on Sarcoma (Geis) by Martinez-Trufero, J., Alvarez Alvarez, R., Lopez Pousa, A., Sevilla, I., Sancho Marquez, P., Orbegoso, C., Cruz Jurado, J., Sala Gonzalez, M.A., Valverde Morales, C., Blanco Sanchez, M.J., Pérez-Fidalgo, J.A., Berros, J.P., Martinez García, J., Arranz, J.L., Meana, A., López-Martín, J.A., Rubió, J., Cano, J.M., Juez-Martel, I., Martin Broto, J.

Get full text

1453PSOLITARY FIBROUS TUMOR (SFT): A REGISTRY PROGRAM TO ASSESS FREQUENCY AND MANAGEMENTE IN OUR COUNTRY. A SPANISH GROUP FOR RESEARCH ON SARCOMA (GEIS) STUDY by Cruz Jurado, J., Valverde Morales, C., Vaz, M.A., Alvarez Alvarez, R., Lopez-Pousa, A., Sancho Marquez, P., Carrasco, J.A., Martinez-Trufero, J., Sala Gonzalez, M.A., Arranz, J.L., De Sande González, L.M., Blanco Sanchez, M.J., Orbegoso, C., Pérez-Fidalgo, J.A., Martinez García, J., Lavernia, J., Sevilla, I., Cano, J.M., Meana, A., Martin Broto, J.

“…Abstract Aim: SFT are soft tissue sarcomas with low incidence and intermediate biological potential behavior. The main aim of this observational study is to…”
Get full text